Alembic Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 533573 |
NSE Symbol : APLLTD |
P/E(TTM) : 27.06 |
ISIN Demat : INE901L01018 |
Div & Yield% : 1.04 |
EPS(TTM) : 38.99 |
Book Value(₹) : 255.98 |
Market Cap(₹Cr) : 20,737.41 |
Face Value(₹) : 2.00 |
Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 37.70 |
Reserves | 4,869.60 | 4,374.99 | 5,251.03 | 5,062.50 | 3,308.31 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 4,908.91 | 4,414.30 | 5,290.34 | 5,101.81 | 3,346.01 |
Secured Loans | 100.04 | 165.07 | 0.00 | 0.02 | 0.04 |
Unsecured Loans | 391.95 | 544.86 | 706.12 | 583.59 | 1,686.99 |
Total Debt | 491.99 | 709.93 | 706.12 | 583.61 | 1,687.03 |
Other Liabilities | 109.51 | 106.20 | 95.82 | 85.52 | 146.51 |
Total Liabilities | 5,510.41 | 5,230.43 | 6,092.28 | 5,770.94 | 5,179.55 |
APPLICATION OF FUNDS : | |||||
Gross Block | 3,859.15 | 3,441.27 | 2,733.10 | 2,452.31 | 1,761.67 |
Less: Accumulated Depreciation | 1,323.49 | 1,063.82 | 962.00 | 678.49 | 485.21 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 2,535.66 | 2,377.45 | 1,771.10 | 1,773.82 | 1,276.46 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 524.36 | 601.28 | 2,304.23 | 2,182.53 | 1,569.98 |
Investments | 226.68 | 229.27 | 219.36 | 343.09 | 833.25 |
Current Assets, Loans & Advances | |||||
Inventories | 1,353.07 | 1,275.13 | 1,396.83 | 1,341.96 | 1,073.18 |
Sundry Debtors | 1,340.12 | 1,201.20 | 988.33 | 421.86 | 784.11 |
Cash and Bank Balance | 26.49 | 28.46 | 21.90 | 61.44 | 37.13 |
Loans and Advances | 268.87 | 275.43 | 337.41 | 482.37 | 256.95 |
Total Current Assets | 2,988.55 | 2,780.22 | 2,744.47 | 2,307.63 | 2,151.37 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 823.25 | 830.03 | 871.72 | 772.70 | 615.29 |
Provisions | 64.88 | 69.96 | 63.64 | 53.71 | 38.17 |
Total CL & Provisions | 888.13 | 899.99 | 935.36 | 826.41 | 653.46 |
Net Current Assets | 2,100.42 | 1,880.23 | 1,809.11 | 1,481.22 | 1,497.91 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 210.11 | 161.30 | 151.29 | 142.80 | 114.49 |
Deferred Tax Liability | 131.28 | 83.14 | 197.69 | 188.92 | 160.25 |
Net Deferred Tax | 78.83 | 78.16 | -46.40 | -46.12 | -45.76 |
Other Assets | 44.46 | 64.04 | 34.88 | 36.40 | 47.71 |
Total Assets | 5,510.41 | 5,230.43 | 6,092.28 | 5,770.94 | 5,179.55 |
Contingent Liabilities | 65.03 | 117.45 | 62.87 | 100.46 | 190.28 |